Drug Abuse Prevention Intervention Research

The summary for the Drug Abuse Prevention Intervention Research grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Drug Abuse Prevention Intervention Research: - The goals of this program announcement are to encourage investigations of cognitive, behavioral, and social processes as they relate to: 1) the development of novel drug abuse prevention approaches; 2) the efficacy and effectiveness of newly developed and/or modified prevention programs; 3) the processes associated with the selection, adoption, adaptation, implementation, sustainability, and financing of empirically validated interventions; and 4) methodologies appropriate for studying complex aspects of prevention science. - The total amount to be awarded depends on the scientific merit of applications and the funds available in NIDA's general funding pool. - The types of mechanisms supported under this PA are the R01, R03, and R21. - Eligible organizations include for-profit, not-for-profit, public and private organizations, units of state and local governments, eligible agencies of the federal Government, domestic or foreign institutions/organizations, faith- and community-based organizations, and Native American tribal organizations. - Eligible principal investigators include any individual with the skills, knowledge and resources necessary to carry out the proposed research. - Applicants may submit more than one application, provided they are scientifically distinct - See Section IV.1 for application materials. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088
Federal Grant Title: Drug Abuse Prevention Intervention Research
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-05-118
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Jun 09, 2005
Creation Date: Dec 07, 2006
Archive Date: Feb 03, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses Special district governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses Public and State controlled institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com